BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Drug Development

  Complete Study Results Comparing Cell Therapeutics, Inc.'s OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology

  July 7, 2008

   · 

  6 min read
• Drug Development

  Medivation, Inc. to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington’s Disease

  July 7, 2008

   · 

  2 min read
• Business

  Thermage, Inc. and Reliant Technologies, Inc. to Join Forces Transaction Valued at Approximately $95 Million

  July 7, 2008

   · 

  9 min read
• FDA

  Becton, Dickinson and Company (JOBS) Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections BD GeneOhm(TM) Cdiff Assay Submitted for FDA (JOBS) Clearance

  July 7, 2008

   · 

  4 min read
• Drug Development

  BrainStorm Cell Therapeutics Inc. Study Positive for Spinal Cord Injuries

  July 7, 2008

   · 

  5 min read
• BioForest

  Angiotech Pharmaceuticals, Inc. (JOBS) to Create New Unit; Investors to Buy Convertible Notes

  July 7, 2008

   · 

  11 min read
• Drug Development

  GeoVax Labs Inc. Reports Progress on Its AIDS Vaccine Technology

  July 7, 2008

   · 

  6 min read
• Pharm Country

  Precision Therapeutics, Inc. President and CEO Sean McDonald Named Ernst & Young LLP Entrepreneur of the Year(R) 2008 Regional Award Winner

  July 7, 2008

   · 

  2 min read
• Job Trends

  Introgen Therapeutics, Inc. Cuts 29% of Jobs as it Moves to Market Cancer Therapy

  July 7, 2008

   · 

  6 min read
• Pharm Country

  OLIGOMERIX Funded by the Alzheimer’s Drug Discovery Foundation to Evaluate Compounds Active Against Tau Oligomers, a Novel Target for Therapeutic Development

  July 7, 2008

   · 

  1 min read